lifemd is a comprehensive one-stop telemedicine/telehealth solution with a platform that provides a fully integrated telehealth solution to connect physicians, medical providers, pharmacists, and patients worldwide. the platform is hipaa-compliant and all interactions and communication between physicians, healthcare providers and patients are aes-encrypted. the platform allows physicians, healthcare providers and patients to securely connect and manage common medical conditions. lifemd also custom fabricates mobile diagnostic telehealth equipment such as cases, carts and kiosks. the service is available 24/7/365.
Company profile
Ticker
LFMD, LFMDP
Exchange
Website
CEO
Justin Schreiber
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
CONVERSION LABS, INC., Immudyne, Inc.
SEC CIK
Corporate docs
Subsidiaries
WorkSimpli Software LLC • Springbox Technologies LLC • Taylor Technologies Inc ...
LFMD stock data
Latest filings (excl ownership)
S-8
Registration of securities for employees
15 Mar 24
10-K
2023 FY
Annual report
11 Mar 24
S-8
Registration of securities for employees
21 Dec 23
8-K
LifeMD and Medifast Partner to Offer Transformative Weight Management Solution
13 Dec 23
8-K
Departure of Directors or Certain Officers
14 Nov 23
10-Q
2023 Q3
Quarterly report
8 Nov 23
8-K
Regulation FD Disclosure
10 Aug 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
8-K
Departure of Directors or Certain Officers
31 Jul 23
8-K
Departure of Directors or Certain Officers
14 Jul 23
Transcripts
LFMD
Earnings call transcript
2023 Q4
11 Mar 24
LFMD
Earnings call transcript
2023 Q3
8 Nov 23
LFMD
Earnings call transcript
2023 Q2
9 Aug 23
LFMD
Earnings call transcript
2023 Q1
12 May 23
LFMD
Earnings call transcript
2023 Q1
22 Mar 23
LFMD
Earnings call transcript
2022 Q3
11 Nov 22
LFMD
Earnings call transcript
2022 Q2
11 Aug 22
LFMD
Earnings call transcript
2022 Q1
13 May 22
LFMD
Earnings call transcript
2021 Q4
8 Mar 22
LFMD
Earnings call transcript
2021 Q3
11 Nov 21
Latest ownership filings
4
NAVEEN BHATIA
5 Apr 24
4
Eric Harold Yecies
25 Mar 24
4
MARIA E. STAN
25 Mar 24
4
Stefan Galluppi
25 Mar 24
4
Marc David Benathen
25 Mar 24
4
Nicholas P Alvarez
25 Mar 24
4
NAVEEN BHATIA
14 Mar 24
SC 13G/A
Divisadero Street Capital Management, LP
14 Feb 24
4
Justin Schreiber
15 Nov 23
4
Piyush Jindal
8 Nov 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 15.29 mm | 15.29 mm | 15.29 mm | 15.29 mm | 15.29 mm | 15.29 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.52 mm | 1.89 mm | (no burn) | (no burn) |
Cash used (since last report) | n/a | n/a | 10.43 mm | 12.95 mm | n/a | n/a |
Cash remaining | n/a | n/a | 4.86 mm | 2.34 mm | n/a | n/a |
Runway (months of cash) | n/a | n/a | 3.2 | 1.2 | n/a | n/a |
Institutional ownership, Q2 2023
21.3% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 53 |
Opened positions | 12 |
Closed positions | 3 |
Increased positions | 15 |
Reduced positions | 13 |
13F shares | Current |
---|---|
Total value | 22.20 bn |
Total shares | 8.59 mm |
Total puts | 16.57 k |
Total calls | 38.70 k |
Total put/call ratio | 0.4 |
Largest owners | Shares | Value |
---|---|---|
Stefan Galluppi | 1.65 mm | $0.00 |
Integrated Core Strategies | 1.27 mm | $12.35 mm |
Royce & Associates | 1.02 mm | $4.44 bn |
Vanguard | 731.11 k | $3.18 bn |
EAM Investors | 476.53 k | $2.07 bn |
RILY B. Riley Financial | 463.82 k | $2.02 bn |
BLK Blackrock | 385.79 k | $1.68 bn |
AFG American Financial | 340.00 k | $1.48 mm |
Granahan Investment Management | 305.99 k | $1.33 bn |
Geode Capital Management | 227.55 k | $989.86 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
4 Apr 24 | Naveen Bhatia | Common Stock | By will or laws of descent | Acquire W | No | No | 0 | 500 | 0.00 | 488,599 |
21 Mar 24 | Nicholas P Alvarez | Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 405,000 |
21 Mar 24 | Marc David Benathen | Common Stock | Grant | Acquire A | No | No | 0 | 75,000 | 0.00 | 302,554 |
21 Mar 24 | Stefan Galluppi | Common Stock | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 42,449 |
21 Mar 24 | Maria E. Stan | Common Stock | Grant | Acquire A | No | No | 0 | 20,000 | 0.00 | 28,125 |
News
BTIG Maintains Buy on LifeMD, Raises Price Target to $14
23 Apr 24
BTIG Maintains Buy on LifeMD, Raises Price Target to $13
15 Mar 24
Craig-Hallum Maintains Buy on LifeMD, Raises Price Target to $15
12 Mar 24
B. Riley Securities Reiterates Buy on LifeMD, Raises Price Target to $12
12 Mar 24
Cantor Fitzgerald Maintains Overweight on LifeMD, Raises Price Target to $11
12 Mar 24